Artelo Biosciences gets U.S. patent allowance for ART27.13 drug

Go back to Artelo Biosciences gets U.S. patent allowance for ART27.13 drug
ARISTOTLE (NASDAQ: ARTL) Delayed: 5.43 -0.2 (3.55%)
Previous Close $5.63    52 Week High $6.22 
Open $5.69    52 Week Low $2.74 
Day High $5.84    P/E N/A 
Day Low $5.35    EPS $-0.21 
Volume 41,096